The Trump Administration is Calling for Your Input on Marijuana Rescheduling

The federal government is preparing their position for the United Nation's next Commission on Narcotic Drugs.

The federal government wants to hear what you have to say about the rescheduling of cannabis as they prepare their position for the United Nation's next Commission on Narcotic Drugs.

In January, the World Health Organization officially recommended that the United Nations should reclassify cannabis and its derivatives. Under the 1961 Single Convention on Narcotic Drugs, marijuana was designated a Schedule I substance, meaning it was considered to have no medicinal value whatsoever, and was therefore banned by all member states.

While cannabis has retained its designation ever since, several member states including CanadaGeorgia, and Uruguay have legalized the substance within their borders in the intervening years. This momentum has prompted further effort on behalf of the UN to reassess the rescheduling of cannabis.

The upcoming 62nd session for the Commission on Narcotic Drugs, taking place from March 14th to the 22nd, will be the first time that the Commission will be able to vote on the WHO's much-delayed recommendation.

This week, the FDA put out a formal request for public comments on the website, which allows citizens to provide their two cents on the matter, which will then be considered while preparing the United States' position on the proposal to reschedule the drug.

While this is not the first time that the Trump administration has called for public comment on the UN's approach to the marijuana issue, it will be the first time that the US will be announcing their position since the WHO has given cannabis their seal of approval.

This article first appeared on Civilized.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Clarice Gomes

Clarice, a Melbourne-based writer, began her career covering the technology industry and now writes, edits and interviews subject matter experts in the Cannabis Industry.

Leave a Reply

Your email address will not be published. Required fields are marked *